KURA · Kura Oncology, Inc.
$11.13
+0.27 (+2.44%)
At close · Aug 17
Market Cap
$966.11M
Shares
88.96M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding KURA
176 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 2,726,738 | $22,168,380 | 0.00% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 2,523,230 | $20,513,860 | 0.28% | Long | 2026-03-31 | |
| iShares Russell 2000 ETF | — | 1,967,638 | $15,996,897 | 0.02% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 974,770 | $7,924,880 | 0.01% | Long | 2026-03-31 | |
| Fidelity Small Cap Index Fund | — | 795,686 | $7,025,907 | 0.02% | Long | 2026-04-30 | |
| BlackRock Advantage Small Cap Core Fund | — | 564,979 | $5,762,786 | 0.11% | Long | 2026-05-29 | |
| iShares Russell 2000 Value ETF | — | 691,817 | $5,624,472 | 0.05% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 628,449 | $5,109,290 | 0.06% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 451,547 | $4,605,779 | 0.01% | Long | 2026-05-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 414,458 | $4,227,472 | 0.02% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | — | 413,820 | $4,220,964 | 0.02% | Long | 2026-05-31 | |
| ROYCE MICRO-CAP TRUST, INC. | RMT | 231,876 | $2,543,680 | 0.28% | Long | 2026-06-30 | |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND | — | 300,321 | $2,441,610 | 0.10% | Long | 2026-03-31 | |
| U.S. SMALL CAP PORTFOLIO | — | 268,920 | $2,374,564 | 0.01% | Long | 2026-04-30 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 231,658 | $2,362,912 | 0.01% | Long | 2026-05-31 | |
| VANGUARD EXPLORER FUND | — | 245,051 | $2,163,800 | 0.01% | Long | 2026-04-30 | |
| Multi-Manager Small Cap Equity Strategies Fund | — | 202,368 | $2,064,154 | 0.16% | Long | 2026-05-31 | |
| Fidelity Enhanced Small Cap ETF | — | 236,158 | $1,919,965 | 0.05% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 160,631 | $1,638,436 | 0.00% | Long | 2026-05-31 | |
| Schwab Small-Cap Index Fund | — | 175,097 | $1,546,107 | 0.02% | Long | 2026-04-30 | |
| Dimensional U.S. Small Cap ETF | — | 166,511 | $1,470,292 | 0.01% | Long | 2026-04-30 | |
| ROYCE SMALL-CAP TRUST, INC. | RVT | 130,124 | $1,427,460 | 0.05% | Long | 2026-06-30 | |
| Invesco RAFI US 1500 Small-Mid ETF | — | 159,881 | $1,411,749 | 0.05% | Long | 2026-04-30 | |
| Dimensional U.S. Core Equity 2 ETF | — | 154,436 | $1,363,670 | 0.00% | Long | 2026-04-30 | |
| Fidelity Series Total Market Index Fund | — | 133,531 | $1,362,016 | 0.00% | Long | 2026-05-31 | |
| iShares Genomics Immunology and Healthcare ETF | — | 150,470 | $1,328,650 | 0.83% | Long | 2026-04-30 | |
| Direxion Daily S&P Biotech Bull 3X Shares | — | 144,395 | $1,275,008 | 0.25% | Long | 2026-04-30 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 151,998 | $1,235,744 | 0.00% | Long | 2026-03-31 | |
| U.S. MICRO CAP PORTFOLIO | — | 138,729 | $1,224,977 | 0.02% | Long | 2026-04-30 | |
| Royce Small-Cap Fund | — | 110,551 | $1,212,744 | 0.06% | Long | 2026-06-30 | |
| NVIT Multi-Manager Small Company Fund | — | 145,981 | $1,186,826 | 0.33% | Long | 2026-03-31 | |
| Avantis U.S. Small Cap Value Fund | — | 110,679 | $1,128,926 | 0.06% | Long | 2026-05-31 | |
| Master Small Cap Index Series | — | 137,018 | $1,113,956 | 0.02% | Long | 2026-03-31 | |
| SMALL CAP EQUITY FUND | — | 135,479 | $1,101,444 | 0.13% | Long | 2026-03-31 | |
| Royce Micro-Cap Fund | — | 100,058 | $1,097,636 | 0.26% | Long | 2026-06-30 | |
| ALPS Medical Breakthroughs ETF | — | 91,050 | $928,710 | 0.57% | Long | 2026-05-31 | |
| Nuveen Small Cap Blend Index Fund | — | 98,481 | $869,587 | 0.02% | Long | 2026-04-30 | |
| Virtus Biotech Etf | — | 92,599 | $817,649 | 1.38% | Long | 2026-04-30 | |
| Fidelity Small Cap Value Index Fund | — | 99,858 | $811,846 | 0.05% | Long | 2026-03-31 | |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | — | 75,402 | $769,100 | 0.08% | Long | 2026-05-31 | |
| U.S. CORE EQUITY 1 PORTFOLIO | — | 85,813 | $757,729 | 0.00% | Long | 2026-04-30 | |
| BlackRock Advantage Small Cap Growth Fund | — | 92,152 | $749,196 | 0.11% | Long | 2026-03-31 | |
| U.S. CORE EQUITY 2 PORTFOLIO | — | 80,933 | $714,638 | 0.00% | Long | 2026-04-30 | |
| EQ/2000 Managed Volatility Portfolio | — | 85,789 | $697,465 | 0.02% | Long | 2026-03-31 | |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND | — | 66,519 | $678,494 | 0.05% | Long | 2026-05-31 | |
| Diversified Equity Master Portfolio | — | 83,422 | $678,221 | 0.02% | Long | 2026-03-31 | |
| NVIT Small Cap Value Fund | — | 76,572 | $622,530 | 0.33% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 59,708 | $609,022 | 0.00% | Long | 2026-05-31 | |
| LVIP State Street Small-Cap Index Fund | — | 55,399 | $607,727 | 0.03% | Long | 2026-06-30 | |
| Strategic Advisers U.S. Total Stock Fund | — | 54,314 | $554,003 | 0.00% | Long | 2026-05-31 |
Showing 1–50 of 176 positions
Key facts
CIK
1422143
CUSIP
50127T109
13F (30d)
222 filings
204 filers
Visit website
Investor relations